CERUS INTERCEPT-Blood Products

The Naval Medical Logistics Command intends to negotiate a sole source contract with Cerus Corporation for the supply of INTERCEPT platelet small volume processing sets, INTERCEPT platelet processing sets with dual storage containers, shipping, and two annual technical service representative visits to support an existing pathogen reduction system at the United States Naval Hospital in Guam. The base year contract plus four option years is valued at an estimated annual total for each contract line item. Interested parties must submit capability statements by February 21, 2020 demonstrating their ability to provide the same products and services to be considered for the requirement.

There is no set-aside designation for this requirement. The anticipated NAICS code is 325413 with an estimated contract value over 5 years of $5-10 million. Cerus Corporation is identified as the potential incumbent due to their supply of these products for the existing system. Estimated annual quantities are provided for the INTERCEPT platelet processing sets and shipping for the base year and each option year.